Topic Editors

Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, No. 2 Yuanmingyuan West Road, Beijing 100193, China
College of Veterinary Medicine, Northeast Agricultural University, 600 Changjiang Road, Xiangfang District, Harbin 150030, China

Recent Advances in Veterinary Pharmacology and Toxicology

Abstract submission deadline
31 October 2024
Manuscript submission deadline
31 December 2024
Viewed by
215

Topic Information

Dear Colleagues,

Nowadays, veterinary pharmacology and toxicology should be regarded as disciplines contributing to the “One Health” paradigm, reducing risk at the animal–human ecosystem. The use of antibiotics plays a crucial role in maintaining the safety, health, and rapid development of the animal husbandry industry. In the past 30 years, the fields of veterinary pharmacology and toxicology have experienced rapid development and achieved a series of important results. For example, in 2015, Chinese scientists from the fields of veterinary pharmacology and toxicology first discovered the colistin resistance gene MCR-1. Currently, the development of new veterinary drugs and the rational use of existing antibacterial drugs are hot topics in this field, and some progress has been made in recent years. Therefore, we call on scientists in this field to submit their latest research, including but not limited to bacterial resistance, combination therapy, drug toxicology and molecular mechanisms, and new drug development. We hope to attract more scholars to veterinary pharmacology and toxicology and promote the exchange and development of these disciplines through this Topic.

Prof. Dr. Chongshan Dai
Prof. Dr. Jichang Li
Topic Editors

Keywords

  • veterinary science
  • drug therapy
  • natural products
  • pharmacology
  • toxicology
  • antioxidants
  • combination therapy
  • cell death
  • bacterial infection

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Antioxidants
antioxidants
7.0 8.8 2012 13.9 Days CHF 2900 Submit
Journal of Xenobiotics
jox
6.0 4.6 2011 21.7 Days CHF 1600 Submit
Metabolites
metabolites
4.1 5.3 2011 13.2 Days CHF 2700 Submit
Molecules
molecules
4.6 6.7 1996 14.6 Days CHF 2700 Submit
Toxics
toxics
4.6 3.4 2013 14.7 Days CHF 2600 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
21 pages, 2419 KiB  
Article
Ozone Therapy in the Integrated Treatment of Female Dogs with Mammary Cancer: Oxidative Profile and Quality of Life
by Laís Pereira Silva, Ricardo Wagner Portela, Marília Carneiro Machado, Gisele André Baptista Canuto, João Moreira Costa-Neto, Vitor de Moraes Pina de Carvalho, Hanna Carvalho de Sá, Karine Araújo Damasceno, Vinicius Ricardo Cuña de Souza, Clarisse Simões Coelho and Alessandra Estrela-Lima
Antioxidants 2024, 13(6), 673; https://doi.org/10.3390/antiox13060673 (registering DOI) - 30 May 2024
Abstract
Considering the high frequency of malignant breast tumors, there is a growing search for new therapeutic strategies that control neoplastic growth and dissemination, combined with fewer adverse reactions. Therefore, this study evaluated the effects of ozone therapy in female dogs with mammary cancer [...] Read more.
Considering the high frequency of malignant breast tumors, there is a growing search for new therapeutic strategies that control neoplastic growth and dissemination, combined with fewer adverse reactions. Therefore, this study evaluated the effects of ozone therapy in female dogs with mammary cancer undergoing chemotherapy treatment. Twenty-five canines diagnosed with malignant mammary neoplasia were divided into two groups: one treated with carboplatin alone (n = 11) and the other with carboplatin associated with ozone therapy (n = 14). Clinical and laboratory evaluations, mastectomy, analysis of the oxidative profile based on total antioxidant capacity (TAC) and serum concentrations of malondialdehyde (MDA), survival rate, and quality of life were performed. Animals in the ozone therapy group had higher concentrations of red blood cells and platelets, significantly improving the survival rate and quality of life. Furthermore, adverse reactions were less intense and frequent in this group, which was associated with an increase in TAC and a reduction in MDA. These results indicate that the combination of carboplatin and ozone therapy represents a promising complementary treatment for female dogs with mammary cancer, as it was associated with fewer adverse reactions and a better oxidative profile. Full article
(This article belongs to the Topic Recent Advances in Veterinary Pharmacology and Toxicology)
Show Figures

Figure 1

Back to TopTop